新闻
2026-11-12
Vittoria Biotherapeutics Announces FDA RMAT and Orphan Drug Designations for Senza5 CART5 (VIPER-101) in T-Cell Lymphoma
免疫疗法孤儿药细胞疗法ASH会议
2026-11-12
NervGen Receives FDA Breakthrough Therapy Designation for NVG-291 in Chronic Spinal Cord Injury
快速通道临床结果突破性疗法孤儿药
2026-11-12
Bayer's asundexian wins first-in-class approval in US to prevent repeat strokes
上市批准临床结果
2026-11-12
Corsair Pharma Announces Positive Outcome from FDA Pre-IND Meeting for TRX-248 Transdermal System for Pulmonary Arterial Hypertension (PAH)
临床1期临床申请临床结果
2026-11-12
Hinge Bio Shares Encouraging Clinical Data for HB2198, a Novel B-Cell Depleting Agent for Treating Autoimmune Disease, at ACR Convergence 2026
免疫疗法AACR会议
2026-11-12
Merck Announces Positive Results from Phase 2b Trial of Efinopegdutide in Adults with Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Stage 2-3 Fibrosis
临床结果快速通道引进/卖出
2026-11-11
Adneuris Therapeutics Reaches Key Regulatory Milestone with FDA Submission of New Drug Application for Cebranopadol in Moderate-to-Severe Acute Pain
临床结果快速通道
Boehringer Ingelheim's survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase III SYNCHRONIZE-CVOT trial alongside significant cardiometabolic benefits
临床结果快速通道突破性疗法AHA会议
2026-11-10
J&J's bispecific combo shows early promise in prostate cancer study
临床结果免疫疗法ASCO会议
2026-11-10
Skyhawk Therapeutics Announces First U.S. Patients Dosed in Pivotal FALCON-HD Study Evaluating SKY-0515 in Huntington’s Disease